Screener
PJP vs PSCH
Invesco Pharmaceuticals ETF vs Invesco S&P SmallCap Health Care ETF
Key differences
- PSCH costs 0.28% less per year.
- Over the last 3 years, PJP has delivered higher annualized returns.
- PJP has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| PJP | PSCH | |
|---|---|---|
| Annual cost (TER) | 0.57% | 0.29% |
| Fund size (AUM) | $334M | $129M |
| Since | 2005 | 2010 |
| Dividend yield | 1.01% | 0.01% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +40.6% | +11.0% |
| CAGR 3Y | +14.0% | +0.9% |
| CAGR 5Y | +7.8% | -5.7% |
| Sharpe 3Y | 0.69 | -0.01 |
| Volatility 1Y | 16.23% | 20.30% |
| Max drawdown | -33.95% | -47.32% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PJP and PSCH
Explore further